Fentanyl Injectable Syringes Recalled for Sterility Assurance Concerns
Central Admixture Pharmacy Services is recalling 2,340 fentanyl syringes distributed nationwide due to lack of sterility assurance from unvalidated sanitization procedures.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall of a high-risk injectable medication (fentanyl) where sterility assurance is compromised due to unvalidated sanitization procedures. No illnesses or injuries have been reported; the hazard is potential contamination that could cause serious infection if the product was compromised.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling fentanyl in 0.9% sodium chloride (10 mcg/1 mL) supplied in 3 mL syringes. The recall affects 2,340 units distributed nationwide in the USA.
The recall was issued because the manufacturer lacked validation data for the sanitization cycles used during manufacturing. This insufficient validation means sterility of the product cannot be assured.
The affected lot numbers are 17-270813 (expiration 7/19/2023), 17-271485 (7/31/2023), 17-271809 (8/6/2023), 17-272314 (8/14/2023), 17-272780 (8/22/2023), 17-273141 (8/29/2023), and 17-273687 (9/6/2023). The product is distributed under NDC 71286-2071-7.
Healthcare providers and patients should stop using affected syringes immediately. Units with these lot numbers should be removed from use and returned to the manufacturer if possible. Contact Central Admixture Pharmacy Services or the FDA with any questions about this recall.
The recalled product
- Product
- fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-7
- Manufacturer
- Central Admixture Pharmacy Services Inc
- Category
- Drug — Injectable / Fentanyl
- Hazard
- lack-of-sterility
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (14)
- Lot: 17-270813
- Exp. 7/19/2023
- 17-271485
- Exp. 7/31/2023
- 17-271809
- Exp. 8/6/2023
- 17-272314
- Exp. 8/14/2023
- 17-272780
- Exp. 8/22/2023
- 17-273141
- Exp. 8/29/2023
- 17-273687
- Exp. 9/6/2023.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27